PILOT TRIAL OF AN ORAL TWICE-DAILY NEW L-VALYL ESTER OF ACYCLOVIR (VALACYCLOVIR) FOR PROPHYLAXIS AGAINST HERPES-SIMPLEX VIRUS (HSV) IN BONE-MARROW TRANSPLANT PERIPHERAL STEM-CELL (BMT) PATIENTS

Citation
J. Essell et al., PILOT TRIAL OF AN ORAL TWICE-DAILY NEW L-VALYL ESTER OF ACYCLOVIR (VALACYCLOVIR) FOR PROPHYLAXIS AGAINST HERPES-SIMPLEX VIRUS (HSV) IN BONE-MARROW TRANSPLANT PERIPHERAL STEM-CELL (BMT) PATIENTS, Blood, 90(10), 1997, pp. 2421-2421
Citations number
NO
Categorie Soggetti
Hematology
Journal title
BloodACNP
ISSN journal
00064971
Volume
90
Issue
10
Year of publication
1997
Part
1
Supplement
1
Pages
2421 - 2421
Database
ISI
SICI code
0006-4971(1997)90:10<2421:PTOAOT>2.0.ZU;2-T